RCUS filings
Corporate insider profile
Robert C. Goeltz Ii Filing Activity
Latest reported as Chief Financial Officer of Arcus Biosciences, Inc. (RCUS).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$198,965.69
- Latest transaction
- May 11, 2026
Affiliated corporations
Reported company relationships
Transaction history
